Edition:
India

Cantel Medical Corp (CMD.N)

CMD.N on New York Stock Exchange

70.68USD
21 Oct 2019
Change (% chg)

$-0.38 (-0.53%)
Prev Close
$71.06
Open
$71.60
Day's High
$71.60
Day's Low
$70.68
Volume
1,630
Avg. Vol
69,969
52-wk High
$93.77
52-wk Low
$63.52

Latest Key Developments (Source: Significant Developments)

Cantel Medical Reports Q4 Non-GAAP Earnings Per Share $0.63
Monday, 23 Sep 2019 

Sept 23 (Reuters) - Cantel Medical Corp ::CANTEL MEDICAL REPORTS FINANCIAL RESULTS FOR ITS FOURTH QUARTER FISCAL YEAR 2019.Q4 NON-GAAP EARNINGS PER SHARE $0.63.Q4 GAAP EARNINGS PER SHARE $0.21.Q4 SALES $239.5 MILLION VERSUS REFINITIV IBES ESTIMATE OF $238.1 MILLION.Q4 EARNINGS PER SHARE ESTIMATE $0.61 -- REFINITIV IBES DATA.QTRLY NET SALES WERE $239.5 MILLION, UP 4.6% COMPARED TO PRIOR YEAR.EXCLUDING IMPACT FROM FOREIGN CURRENCY, QTRLY NET SALES INCREASED BY 5.6%, DRIVEN BY ORGANIC GROWTH OF 3.4%.Q4 ENDED WITH CASH OF $44.5 MILLION.EXPECT HU-FRIEDY ACQUISTION TO CLOSE IN Q1 OF FISCAL YEAR 2020.  Full Article

Cantel To Acquire Hu-Friedy For $725 Million
Tuesday, 30 Jul 2019 

July 30 (Reuters) - Cantel Medical Corp ::CANTEL TO ACQUIRE HU-FRIEDY.CANTEL MEDICAL CORP - CANTEL IS ACQUIRING HU-FRIEDY FOR $725 MILLION IN UPFRONT CASH AND STOCK CONSIDERATION,.CANTEL MEDICAL CORP - DEAL EXPECTED TO BE 10 PERCENT ACCRETIVE TO NON-GAAP EARNINGS PER SHARE IN FY 2020.CANTEL MEDICAL - DEAL INCLUDES UP TO $50 MILLION IN EARNOUT PAYMENTS PAYABLE IN CASH AND STOCK CONDITIONAL ON ACHIEVEMENT OF CERTAIN MILESTONES.CANTEL MEDICAL CORP - DEAL EXPECTED TO GENERATE ANNUAL RUN-RATE COST SYNERGIES OF $10+ MILLION BY YEAR 3.CANTEL MEDICAL CORP - TRANSACTION STRUCTURE IS ANTICIPATED TO RESULT IN TAX BENEFITS TO CANTEL PRESENTLY VALUED AT MORE THAN $100 MILLION.CANTEL MEDICAL CORP - NET OF TAX BENEFIT, TOTAL CONSIDERATION IMPLIED WOULD BE $625 MILLION UPFRONT AND UP TO $675 MILLION INCLUDING EARNOUT PAYMENTS..CANTEL MEDICAL CORP - TRANSACTION HAS BEEN APPROVED BY BOARDS OF DIRECTORS OF HU-FRIEDY, CO.CANTEL MEDICAL CORP - TRANSACTION IS EXPECTED TO BE DILUTIVE TO GAAP EARNINGS PER DILUTED SHARE IN FISCAL YEAR 2020.CANTEL MEDICAL CORP - TRANSACTION EXPECTED TO BE ACCRETIVE TO GAAP EARNINGS PER DILUTED SHARE IN FISCAL YEAR 2021 AND BEYOND.CANTEL MEDICAL - CASH PORTION OF DEAL IS BEING FINANCED THROUGH A COMBINATION OF NET PROCEEDS OF COMPANY'S AMENDED AND RESTATED CREDIT FACILITY.  Full Article

Cantel Medical Reports Q3 Earnings Per Share $0.20
Tuesday, 4 Jun 2019 

June 4 (Reuters) - Cantel Medical Corp ::CANTEL MEDICAL REPORTS FINANCIAL RESULTS FOR ITS THIRD QUARTER FISCAL YEAR 2019.Q3 NON-GAAP EARNINGS PER SHARE $0.55.Q3 GAAP EARNINGS PER SHARE $0.20.Q3 SALES $228.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF $227.5 MILLION.Q3 EARNINGS PER SHARE ESTIMATE $0.56 -- REFINITIV IBES DATA.  Full Article

Cantel Medical Reports Q2 Non-GAAP EPS Of $0.57
Thursday, 28 Feb 2019 

Feb 28 (Reuters) - Cantel Medical Corp ::CANTEL MEDICAL REPORTS FINANCIAL RESULTS FOR ITS SECOND QUARTER FISCAL YEAR 2019.Q2 NON-GAAP EARNINGS PER SHARE $0.57.Q2 GAAP EARNINGS PER SHARE $0.45.Q2 SALES $224.5 MILLION VERSUS REFINITIV IBES ESTIMATE OF $226.9 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $0.62 -- REFINITIV IBES DATA.  Full Article

Cantel Medical Reports Q1 Non-GAAP EPS Of $0.62
Thursday, 29 Nov 2018 

Nov 29 (Reuters) - Cantel Medical Corp ::CANTEL MEDICAL REPORTS FINANCIAL RESULTS FOR ITS FIRST QUARTER FISCAL YEAR 2019.Q1 NON-GAAP EARNINGS PER SHARE $0.62.Q1 GAAP EARNINGS PER SHARE $0.46.Q1 SALES $225.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF $227.5 MILLION.  Full Article

Cantel To Acquire Omnia S.P.A
Monday, 12 Nov 2018 

Nov 12 (Reuters) - Cantel Medical Corp ::CANTEL TO ACQUIRE OMNIA S.P.A.CANTEL MEDICAL CORP - TOTAL PURCHASE PRICE IS $31.9 MILLION IN CASH AND STOCK CONSIDERATION,.CANTEL MEDICAL CORP - TOTAL PURCHASE PRICE CONSISTING OF $26.1 MILLION IN UPFRONT PAYMENT AND $5.8 MILLION OF CONSIDERATION IN FORM OF AN EARNOUT.CANTEL MEDICAL CORP - ANTICIPATES ACQUISITION TO BE ACCRETIVE TO NON-GAAP EARNINGS PER SHARE IN FISCAL YEAR ENDING JULY 31, 2019 AND BEYOND.CANTEL MEDICAL CORP - ANTICIPATES DEAL TO BE ACCRETIVE TO GAAP EPS IN FISCAL YEAR ENDING JULY 31, 2020 AND BEYOND.  Full Article

Cantel Expands Its Life Sciences Portfolio Through Acquisition Of Stericycle's Controlled Environmental Solutions Business
Friday, 3 Aug 2018 

Aug 3 (Reuters) - Cantel Medical Corp ::CANTEL EXPANDS ITS LIFE SCIENCES PORTFOLIO THROUGH ACQUISITION OF STERICYCLE'S CONTROLLED ENVIRONMENTAL SOLUTIONS BUSINESS.CANTEL MEDICAL CORP - CANTEL ANTICIPATES ACQUISITION TO BE ACCRETIVE TO NON-GAAP EARNINGS PER SHARE IN FISCAL YEAR ENDING JULY 31, 2019 AND BEYOND.CANTEL MEDICAL CORP - DEAL FOR $17.0 MILLION ON A CASH-FREE AND DEBT-FREE BASIS.CANTEL MEDICAL - EXPECTS DEAL TO BE ACCRETIVE TO GAAP EARNINGS PER SHARE IN FISCAL YEAR ENDING JULY 31, 2020 AND BEYOND.  Full Article

Cantel Medical Corp Chairman Charles Diker Reports Sale Of 10,000 Shares
Thursday, 18 Jan 2018 

Jan 17 (Reuters) - Cantel Medical Corp ::CANTEL MEDICAL CORP CHAIRMAN CHARLES DIKER REPORTS OPEN MARKET SALE OF 10,000 SHARES OF CO'S COMMON STOCK ON JAN 16 AT $110.96 PER SHARE - SEC FILING.  Full Article

Cantel Medical Reports Record Financial Results For Q1 Fiscal Year 2018
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - Cantel Medical Corp ::Q1 SALES ROSE 13.3 PERCENT TO $212.8 MILLION.Q1 NON-GAAP EARNINGS PER SHARE $0.57.Q1 GAAP EARNINGS PER SHARE $0.55.Q1 REVENUE VIEW $207.7 MILLION -- THOMSON REUTERS I/B/E/S.Q1 EARNINGS PER SHARE VIEW $0.54 -- THOMSON REUTERS I/B/E/S.  Full Article